Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
α-(Methyl-d3)-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine Hydrochloride; N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-(1-napthyl)ethylamine-d3 Hydrochloride;
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
rac-Cinacalcet-d3 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
rac-Cinacalcet-d3 Hydrochloride usage and description
Rac-Cinacalcet D3 Hydrochloride is a calcium-sensing receptor agonist that is used in the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD). The drug is a combination of cinacalcet hydrochloride and vitamin D3, which work together to regulate the levels of calcium and phosphate in the body.
Cinacalcet hydrochloride is a calcimimetic agent that binds to and activates the calcium-sensing receptor on the parathyroid gland, which helps to reduce the secretion of parathyroid hormone (PTH). PTH is responsible for increasing the levels of calcium and phosphate in the blood, which can lead to bone loss and calcification of soft tissues. By reducing the levels of PTH, cinacalcet hydrochloride helps to prevent these complications in patients with CKD.
Vitamin D3, on the other hand, is a hormone that is essential for the absorption of calcium in the intestines and the regulation of calcium and phosphate levels in the blood. It works by increasing the expression of calcium transporters in the intestines and kidneys, which helps to enhance the absorption and reabsorption of calcium.
Rac-Cinacalcet D3 Hydrochloride is available in tablet form and is taken orally. The dosage and duration of treatment depend on the severity of the condition and the patient's response to the medication. Common side effects of the drug include nausea, vomiting, diarrhea, and headache. In rare cases, it may cause hypocalcemia (low levels of calcium in the blood) or hypercalcemia (high levels of calcium in the blood). Patients should be monitored regularly for any adverse effects and should consult their doctor if they experience any unusual symptoms.
